New Data on Bevacizumab (Avastin) « Medical Lessons
Links shared publicly online about this topic.
- 456total visits
New Data on Bevacizumab (Avastin) « Medical Lessons
View full resource at medicallessons.net
Tags: Colorectal Cancer Medication, Avastin, Medical
Most Recently Shared on March 7, 2011 at 11:38 pm By:
New Data on Bevacizumab (Avastin) - http://bit.ly/fyPIir
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurrent Ovarian Cancer
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 1:16 pm By:
Debby Verville Health Advocate
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Re... http://bit.ly/m03fYD
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurrent Ovarian Cancer
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 10:05 am By:
MNT Women's Health Health News
Genentech Announces Data To Show Avastin-Based Regimen Halved The Risk Of Disease Getting Worse In Women With Recurren... http://mnt.to/3WNk
Fredericksburg Oncology - Health/Medical/Pharmacy - Fredericksburg, Virginia | Facebook
facebook.com — “Fredericksburg Oncology - Welcome To Fredericksburg Oncology. We are dedicated to providing excellence and compassion in clinical care, and to advancing knowledge in cancer treatment by providing local access to national clinical trials. | Facebook” View full resource at facebook.com
Most Recently Shared on May 26, 2011 at 2:47 am By:
Frederick Tucker Oncologist, Physician, Doctor, Internist, and Psychiatrist
More on the Bevacizumab (Avastin) story in the New York TImes http://www.facebook.com/FredericksburgOncology
Drugs and Profits - NYTimes.com
nytimes.com — “Does Avastin save breast cancer patients? The research says no.” View full resource at nytimes.com
Most Recently Shared on May 25, 2011 at 5:40 pm By:
Frederick Tucker Oncologist, Physician, Doctor, Internist, and Psychiatrist
More on the Bevacizumab (Avastin) story in the New York TImes http://www.nytimes.com/2011/05/25/opinion/25tucker.html?_r=1&ref=opinion
New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting
news-medical.net — “Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.” View full resource at news-medical.net
Most Recently Shared on May 18, 2011 at 3:22 pm By:
Lung Cancer News: New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO ... http://bit.ly/iCbhdI
Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin&” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 3:10 pm By:
Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO: Genentech, a membe... http://bit.ly/ikFF56
New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting
news-medical.net — “Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.” View full resource at news-medical.net
Most Recently Shared on May 18, 2011 at 3:10 pm By:
New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting: Genentech... http://bit.ly/iolak6
Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin&” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 12:05 pm By:
MNT Ovarian Cancer Health News
Genentech To Present Significant Progress In Advanced Skin, Lung And Ovarian Cancers At ASCO http://mnt.to/3W2Y #ovariancancer
Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO(4)
manufacturing.net — “Progress in advanced skin and lung cancers through personalised healthcare. New Phase III data for Avastin in ovarian cancer to be presented” View full resource at manufacturing.net
Most Recently Shared on May 18, 2011 at 9:52 am By:
Roche to present significant progress in advanced skin, lung and ovarian cancers at ASCO(4): Progress in advance... http://bit.ly/lyectS
Roche eye drug debate moves into patient rooms | Reuters
reuters.com — “CHICAGO (Reuters) - Doctors say new data give them more confidence that the cheaper drug Avastin works as well as Lucentis in treating blindness from macular degeneration, but they will need to spend more” View full resource at reuters.com
Most Recently Shared on May 6, 2011 at 12:45 am By:
Hisham Rana, MD Doctor and Physician
News: Roche eye drug debate moves into patient rooms http://reut.rs/iTAfph - Avastin vs. Lucentis. #health #pharma
PharmaLive: New Analysis Representing Largest Available Dataset Highlights Relative Safety of Lucentis (Ranibizumab) Compared to Unlicensed Intravitreal Avastin (Bevacizumab)
pharmalive.com — “PharmaLive: New Analysis Representing Largest Available Dataset Highlights Relative Safety of Lucentis (Ranibizumab) Compared to Unlicensed Intravitreal Avastin (Bevacizumab)” View full resource at pharmalive.com
Most Recently Shared on May 5, 2011 at 7:49 pm By:
PharmaLive Pharma and Health News
Daily Advantage - Novartis: Lucentis Safer Than Avastin for Wet AMD - http://tinyurl.com/3vlp7hz
Medical News: ARVO: Two-Year Safety Equal in AMD Drug Trial - in Ophthalmology, Ophthalmology from MedPage Today
medpagetoday.com — “FORT LAUDERDALE -- Preliminary two-year safety data from the landmark CATT trial of ranibizumab (Lucentis) and bevacizumab (Avastin) for macular degeneration partially reversed conclusions from the on” View full resource at medpagetoday.com
Most Recently Shared on May 2, 2011 at 6:41 pm By:
ARVO: Two-year safety equal in AMD drug trial: http://tinyurl.com/medpgAMD050211
Avastin (Bevacizumab) Is Not Recommended For The Treatment Of Metastatic Breast Cancer In New Guidance From NICE
medicalnewstoday.com — “The National Institute for Health and Clinical Excellence (NICE) has today (23 February) published final guidance to the NHS not recommending the use of bevacizumab (Avastin, Roche Products), when” View full resource at medicalnewstoday.com
Most Recently Shared on February 24, 2011 at 3:05 pm By:
Avastin (Bevacizumab) Is Not Recommended For The Treatment Of Metastatic Breast Cancer In New Guidance From NICE http://mnt.to/3Rwq
Avastin shows promise against retinopathy in premature babies - Related Stories - AAP SmartBrief
smartbrief.com — “Preterm infants with retinopathy who were injected with Genentech's cancer drug Avastin, or bevacizumab, during a study had a disease recurrence rate of 4%, compared with 22% for those given laser therapy. Reporting in the New England Journal of Medicine, researchers said further testing is needed t” View full resource at smartbrief.com
Most Recently Shared on February 21, 2011 at 11:48 pm By:
Clara Song Pediatrician, Physician, and Doctor
Avastin shows promise against retinopathy in premature babies http://sbne.ws/r/6Nkr
Advertisement
